CAS Medical Systems, Inc. Announces 10 New Scientific Abstracts Demonstrating the Use of FORE-SIGHT Absolute Cerebral Oximetry

CAS Medical Systems, Inc. (Nasdaq:CASM) today announced that ten scientific abstracts regarding the use of FORE-SIGHT(R) Absolute Cerebral Oximetry will be presented at the annual meeting of the American Society of Anesthesiologists in New Orleans, October 17-21, 2009.

Abstracts include demonstrations of utility and accuracy in a variety of applications including orthopedic shoulder arthroscopy, carotid surgery, cerebral autoregulation, and non-cerebral applications, as well as an expanded healthy volunteer accuracy study.

Andrew E. Kersey, President and Chief Executive Officer of CASMED, stated, "These studies further contribute to the growing volume of clinical evidence supporting the use of the FORE-SIGHT Absolute Oximeter. We are delighted with the expanded clinical use of FORE-SIGHT and resultant increased volume of clinical studies exploring ways to advance and improve patient management and quality of care."

October 17

Absolute and Trending Accuracy of FORE-SIGHT and INVOS Cerebral Oximeters in Healthy Volunteers. David B. MacLeod, F.R.C.A., Keita Ikeda, Ph.D., Charles Vacchiano, Ph.D., C.R.N.A., Department of Anesthesiology, Duke University Medical Center, Durham, NC. (A298)

October 18

The Incidence of Cerebral Oxygen Desaturation Events during Surgery in the Beach Chair Position. Glenn S. Murphy, M.D., Joseph W. Szokol, M.D., Jessica A. Vaughn, B.A., Jesse H. Marymont, M.D., Jeffery S. Vender, M.D., Department of Anesthesiology, NorthShore University HealthSystem, Evanston, IL. (A620)

October 19

Validation of the FORE-SIGHT Pediatric NIRS Cerebral Oximeter. Barry D. Kussman, M.B.B.Ch., Peter C. Laussen, M.B.B.S., Paul B. Benni, Ph.D., Doff B. McElhinney, M.D., Francis X. McGowan, Jr., M.D., Anesthesiology, Perioperative & Pain Medicine, Children's Hospital Boston and Harvard Medical School, Boston, MA. (A685)

Measurement of Absolute Viscerosomatic Tissue Oxygen Saturation: Preliminary Results. David B. MacLeod, F.R.C.A., Richard J. Ing, M.B.B.Ch., F.C.A. (S.A.), Keita Ikeda, Ph.D., Warwick A. Ames, F.R.C.A., Scott R. Schulman, M.D., Department of Anesthesiology, Duke University Medical Center, Durham, NC. (A931)

Non-Invasive Absolute Cerebral Oximetry (FORE-SIGHT) during Shunting Procedure for Carotid Surgery. Kevin M. Lathouwers, M.D., Cathy S. DeDeyne, M.D., Ph.D., Roel Mestrum, M.D., Geert Lauwers, M.D., Rene J. Heylen, M.D., Ph.D., Department of Anesthesiology, Ziekenhuis Oost-Limburg, Genk, Belgium. (A748)

Risk of Post-Op Complications below Different Cerebral Oxygenation Thresholds during Aortic Surgery. Gregory W. Fischer, M.D., Hung-Mo Lin, Ph.D., Gabriele DiLuozzo, M.D., Randall B. Griepp, M.D., David L. Reich, M.D., Department of Anesthesiology, Mount Sinai School of Medicine, New York, NY. (A897)

October 20

Absolute Cerebral Oximetry (FORE-SIGHT) in Benchchair Positioning for Shoulder Surgery. Kevin M. Lathouwers, M.D., Cathy S. DeDeyne, M.D., Ph.D., Frank Jans, M.D., Ph.D., Jan Truijen, M.D., Rene J. Heylen, M.D., Ph.D., Department of Anesthesiology, Ziekenhuis Oost-Limburg, Genk, Belgium. (A1288)

Non-Invasive Absolute Cerebral Oximetry (FORE-SIGHT) during Carotid Endarterectomy. Kevin M. Lathouwers, M.D., Cathy S. DeDeyne, M.D., Ph.D., Wouter Lansink, M.D., Roel Mestrum, M.D., Rene J. Heylen, M.D., Ph.D., Department of Anesthesiology, Ziekenhuis Oost-Limburg, Genk, Belgium. (A1114)

Real Time Monitoring of Cerebral Blood Flow Autoregulation with NIRS during Cardiac Surgery. Brijen L. Joshi, M.D., Kenneth Brady, M.D., Charles W. Hogue, M.D., Departments of Anesthesiology & Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, MD. (A1102)

October 21

Cerebral Desaturations in Thoracic Surgery: Possible Positive Correlation with Cognitive Dysfunction. Thomas M. Hemmerling, M.D., D.E.A.A., M.Sc., Roy Kazan, Carmelo Minardi, M.D., Samer Charabati, M.S., David Bracco, M.D., Department of Anesthesiology, McGill, Montreal, Quebec, Canada. (A1415)

About CASMED(R) -- Monitoring What's Vital

CAS Medical Systems, Inc. is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The Company's FORE-SIGHT Absolute Cerebral Oximeter is the first cerebral oximeter available with FDA clearance for non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for neonates, infants, children and adults. This information helps avert brain damage or death during surgery and in critical care situations by allowing clinicians to identify patients with dangerously low levels of cerebral oxygen and intervene to reverse the condition.

The Company's product lines include the high-acuity monitoring capabilities of the FORE-SIGHT Cerebral Oximeter, the bedside patient monitoring line of vital signs and cardio-respiratory monitoring products, proprietary non-invasive blood pressure measurement technology, and supplies and service including blood pressure cuffs and products for neonatal intensive care. CASMED products are designed to meet the needs of a full spectrum of patient populations worldwide, ranging from adults to pediatrics and neonates.

For further information regarding CAS Medical Systems, Inc., visit the Company's website at www.casmed.com.

The CAS Medical Systems, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4675

Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future financial performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, the impact of actions and events involving key customers, vendors and lenders, and other risks detailed in the Company's Form 10-K for the year ended December 31, 2008 and other subsequent Securities and Exchange Commission filings.

Such statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms "anticipate," "believe," "estimate," "expect," "may," "objective," "plan," "possible," "potential," "project," "will" and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise.

This news release was distributed by GlobeNewswire, www.globenewswire.com

SOURCE: CAS Medical Systems, Inc.

CONTACT:  CAS Medical Systems, Inc.
Susan Carron, Director of Corporate Communications
203-488-6056
ir@casmed.com

Related terms: belgium, canada, ceo, children, clinical, fda, hospital, manufacturer, medical, medicine, montreal, nasdaq, new york, north carolina, president, product development, products, quebec, respiratory, science, securities, south carolina, surgery, technology, university, utilities